Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients

NCT04656262 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

79

Enrollment

OTHER

Sponsor class

Stopped enrollment too slow to reach the target in a reasonable time frame

Conditions

Soft Tissue Sarcoma Adult

Interventions

DRUG: Cyclophosphamide
DRUG: Doxorubicin

Sponsor

Istituto Oncologico Veneto IRCCS

Collaborators

[object Object]